Dellora Investments LP - Dec 13, 2024 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)

Role
no longer 10% owner
Signature
Dellora Investments LP, /s/ Kevin Pyun, Principal, Dellora Investments GP LLC, its General Partner
Stock symbol
PVLA
Transactions as of
Dec 13, 2024
Transactions value $
$0
Form type
4
Date filed
12/16/2024, 04:18 PM
Previous filing
Nov 18, 2024

Dellora Investments LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Palvella Therapeutics, Inc. is the successor to Pieris Pharmaceuticals, Inc.. After the closing of the merger and financing on 12/13/2024, Dellora Investments LP is no longer a 10% shareholder in the reporting company.